eFFECTOR Therapeutics Ownership 2024 | Who Owns eFFECTOR Therapeutics Now?
Institutional Ownership
2.94%
Insider Ownership
2.91%
Retail Ownership
94.15%
Institutional Holders
2.00
eFFECTOR Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | 1.66% | 0.00% | 67,738 | - | - | 19,651 | Jun 30, 2024 |
BLACKSTONE INC. | 1.28% | 0.00% | 52,343 | - | - | 15,185 | Jun 30, 2024 |
eFFECTOR Therapeutics's largest institutional shareholder is PARALLEL ADVISORS, LLC, holding 1.66% of the company's total share outstanding, currently valued at $19.65K. The top 10 institutional shareholders own together 2.94% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | 1.66% | 0.00% | 67,738 | - | - | 19,651 | Jun 30, 2024 |
BLACKSTONE INC. | 1.28% | 0.00% | 52,343 | - | - | 15,185 | Jun 30, 2024 |
The largest eFFECTOR Therapeutics shareholder by % of total assets is PARALLEL ADVISORS, LLC. The company owns 67.74K shares of eFFECTOR Therapeutics (EFTR), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKSTONE INC. | 1.28% | 0.00% | 52,343 | - | - | 15,185 | Jun 30, 2024 |
PARALLEL ADVISORS, LLC | 1.66% | 0.00% | 67,738 | - | - | 19,651 | Jun 30, 2024 |
As of Jun 30 2024, eFFECTOR Therapeutics's largest institutional buyer is BLACKSTONE INC.. The company purchased 0.00 stocks of EFTR, valued at $15.19K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | 1.66% | 0.00% | 67,738 | - | - | 19,651 | Jun 30, 2024 |
BLACKSTONE INC. | 1.28% | 0.00% | 52,343 | - | - | 15,185 | Jun 30, 2024 |
As of Jun 30 2024, eFFECTOR Therapeutics's biggest institutional seller is PARALLEL ADVISORS, LLC. The company sold 0.00 shares of EFTR, valued at $19.65K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
eFFECTOR Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
ALPS ETF Trust | 0.00% | 43,828 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 829,705 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 330,677 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 9,544 | - | - | Mar 31, 2024 |
ETF Series Solutions | 0.00% | 5,108 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 92,465 | 92,465 | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 15,175 | 15,175 | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 4,205 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 50,531 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,991 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 584 | - | - | Mar 31, 2024 |
eFFECTOR Therapeutics's largest mutual fund holder by % of total assets is "ALPS ETF Trust", owning 43.83K shares, compromising 0.00% of its total assets.
eFFECTOR Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 2 | - |
31 Mar, 24 | 2 | -92.00% |
31 Dec, 23 | 25 | -13.79% |
30 Sep, 23 | 29 | -17.14% |
30 Jun, 23 | 35 | 29.63% |
31 Mar, 23 | 27 | -12.90% |
31 Dec, 22 | 31 | 14.81% |
30 Sep, 22 | 27 | 17.39% |
30 Jun, 22 | 23 | 27.78% |
31 Mar, 22 | 18 | 5.88% |
31 Dec, 21 | 17 | 41.67% |
30 Sep, 21 | 12 | - |
As of 30 Jun 24, 2 institutions are holding eFFECTOR Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 120,081 | - |
31 Mar, 24 | 120,081 | -98.97% |
31 Dec, 23 | 11,685,202 | -50.21% |
30 Sep, 23 | 23,468,478 | -3.95% |
30 Jun, 23 | 24,433,689 | 3.52% |
31 Mar, 23 | 23,602,595 | -2.96% |
31 Dec, 22 | 24,322,398 | 1.54% |
30 Sep, 22 | 23,953,044 | -0.65% |
30 Jun, 22 | 24,110,440 | 7.29% |
31 Mar, 22 | 22,473,205 | 5.01% |
31 Dec, 21 | 21,402,003 | 59.39% |
30 Sep, 21 | 13,427,860 | - |
eFFECTOR Therapeutics (EFTR) has 120.08K shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 2.94% | 9.76% |
31 Mar, 24 | 5.49% | 958.91% |
31 Dec, 23 | 0.76% | 0.03% |
30 Sep, 23 | 49.07% | 1.45% |
30 Jun, 23 | 58.17% | 1.84% |
31 Mar, 23 | 56.20% | 1.61% |
31 Dec, 22 | 59.06% | 1.74% |
30 Sep, 22 | 58.18% | 1.69% |
30 Jun, 22 | 58.64% | 1.94% |
31 Mar, 22 | 55.02% | 1.96% |
31 Dec, 21 | 53.00% | 4.79% |
30 Sep, 21 | 33.25% | - |
As of 30 Jun 24, eFFECTOR Therapeutics is held by 2.94% institutional shareholders, representing a 9.76% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | - | - |
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 10 | -16.67% |
30 Sep, 23 | 12 | -14.29% |
30 Jun, 23 | 14 | 55.56% |
31 Mar, 23 | 9 | -18.18% |
31 Dec, 22 | 11 | - |
30 Sep, 22 | 11 | -15.38% |
30 Jun, 22 | 13 | 62.50% |
31 Mar, 22 | 8 | -33.33% |
31 Dec, 21 | 12 | - |
30 Sep, 21 | 12 | - |
- institutional shareholders have increased their position in EFTR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | -100.00% |
31 Mar, 24 | 2 | -50.00% |
31 Dec, 23 | 4 | 33.33% |
30 Sep, 23 | 3 | - |
30 Jun, 23 | 3 | -50.00% |
31 Mar, 23 | 6 | 100.00% |
31 Dec, 22 | 3 | 50.00% |
30 Sep, 22 | 2 | 100.00% |
30 Jun, 22 | 1 | -66.67% |
31 Mar, 22 | 3 | 50.00% |
31 Dec, 21 | 2 | - |
30 Sep, 21 | - | - |
- institutional shareholders have reduced their position in EFTR stock as of 30 Jun 24 compared to 2 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 2 | - | 120,081 | - | 2.94% | 9.76% | - | - | - | -100.00% |
31 Mar, 24 | 2 | -92.00% | 120,081 | -98.97% | 5.49% | 958.91% | - | -100.00% | 2 | -50.00% |
31 Dec, 23 | 25 | -13.79% | 11,685,202 | -50.21% | 0.76% | 0.03% | 10 | -16.67% | 4 | 33.33% |
30 Sep, 23 | 29 | -17.14% | 23,468,478 | -3.95% | 49.07% | 1.45% | 12 | -14.29% | 3 | - |
30 Jun, 23 | 35 | 29.63% | 24,433,689 | 3.52% | 58.17% | 1.84% | 14 | 55.56% | 3 | -50.00% |
31 Mar, 23 | 27 | -12.90% | 23,602,595 | -2.96% | 56.20% | 1.61% | 9 | -18.18% | 6 | 100.00% |
31 Dec, 22 | 31 | 14.81% | 24,322,398 | 1.54% | 59.06% | 1.74% | 11 | - | 3 | 50.00% |
30 Sep, 22 | 27 | 17.39% | 23,953,044 | -0.65% | 58.18% | 1.69% | 11 | -15.38% | 2 | 100.00% |
30 Jun, 22 | 23 | 27.78% | 24,110,440 | 7.29% | 58.64% | 1.94% | 13 | 62.50% | 1 | -66.67% |
31 Mar, 22 | 18 | 5.88% | 22,473,205 | 5.01% | 55.02% | 1.96% | 8 | -33.33% | 3 | 50.00% |
31 Dec, 21 | 17 | 41.67% | 21,402,003 | 59.39% | 53.00% | 4.79% | 12 | - | 2 | - |
30 Sep, 21 | 12 | - | 13,427,860 | - | 33.25% | - | 12 | - | - | - |
eFFECTOR Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of eFFECTOR Therapeutics's stock was made by SR ONE CAPITAL MANAGEMENT, LLC on Nov 29 2023, selling 430,578 shares at $0.61 per share (valued at $261.15K).
eFFECTOR Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 8 | - | - |
Q1 2024 | 9 | - | - |
Q4 2023 | 2 | 2 | 100.00% |
Q3 2023 | 2 | 2 | 100.00% |
Q2 2023 | 8 | - | - |
Q1 2023 | 10 | - | - |
Q4 2022 | 3 | - | - |
Q3 2022 | 3 | 31 | 9.68% |
Q2 2022 | 19 | 21 | 90.48% |
Q1 2022 | 12 | - | - |
Q4 2021 | 9 | 68 | 13.24% |
Q3 2021 | 38 | 7 | 542.86% |
Q1 2021 | - | 11 | - |
Q3 2020 | - | - | - |
8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by eFFECTOR Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | 2 | - |
Q3 2023 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | 1 | - | - |
Q3 2022 | 1 | 31 | 3.23% |
Q2 2022 | 3 | 21 | 14.29% |
Q1 2022 | 7 | - | - |
Q4 2021 | - | 68 | - |
Q3 2021 | - | - | - |
Q1 2021 | - | - | - |
Q3 2020 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of eFFECTOR Therapeutics's stocks.
EFTR Ownership FAQ
Who Owns eFFECTOR Therapeutics?
eFFECTOR Therapeutics is owned by institutional shareholders (2.94%), insiders (2.91%), and public (94.15%). The largest institutional shareholder of eFFECTOR Therapeutics is PARALLEL ADVISORS, LLC (1.66% of total shares) and the top mutual fund owner is ALPS ETF Trust (0.00% of total shares).
Who are the major institutional shareholders of eFFECTOR Therapeutics?
eFFECTOR Therapeutics's major institutional shareholders are PARALLEL ADVISORS, LLC, and BLACKSTONE INC.. The top five shareholders own together 2.94% of the company's share outstanding.
How many eFFECTOR Therapeutics shareholders are there?
As of Jun 2024, there are 2 institutional shareholders of eFFECTOR Therapeutics.
What percentage of eFFECTOR Therapeutics is owned by PARALLEL ADVISORS, LLC?
PARALLEL ADVISORS, LLC owns 67.74K shares of eFFECTOR Therapeutics, representing 1.66% of the company's total shares outstanding, valued at $19.65K (as of Jun 2024).
What percentage of eFFECTOR Therapeutics is owned by BLACKSTONE INC?
As of Jun 2024, BLACKSTONE INC holds 52.34K shares of eFFECTOR Therapeutics (EFTR), compromising 1.28% of the company, valued at $15.18K.